Good Moonwha Hospital completes 100th BioBridge surgical case milestone.

Fibralign Corp. and its South Korean distributor Healing Solutions, LTD announced today that Good Moonwha Hospital completed its 100th BioBridge case in the surgical treatment of lymphedema. Good Moonhwa is the first medical center in Asia and second worldwide to reach this major milestone, performing the highest number of cases worldwide in the past year.

Since its establishment in 1978, Good Moonhwa Hospital has grown into a general hospital with 16 centers including 17 departments, playing a leading role in developing local care by offering patient-oriented medical services and have emerged into a regional representative general hospital.

Fibralign Selected as a UCSF Rosenman Institute Innovator

Fibralign Selected as a UCSF Rosenman Institute Innovator

NCI-funded study evaluating Fibralign’s BioBridge® as an adjunct to microsurgical treatment SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- The UCSF Rosenman Institute is proud to announce the 2021 cohort of the Rosenman Innovators, a group of early-stage health...

read more